Cargando…

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre

INTRODUCTION: There are conflicting data on prior oral-anticoagulant (OAC) use and outcomes of hospitalized COVID-19 patients. Due to uncertainties regarding associated risks with the prior OAC use, we have investigated this issue in a large cohort of hospitalized COVID-19 patients from our institut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bistrovic, Petra, Sabljic, Anica, Kovacevic, Ivona, Cikara, Tomislav, Keres, Tatjana, Lucijanic, Tomo, Mitrovic, Josko, Delic-Brkljacic, Diana, Manola, Sime, Lucijanic, Marko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701577/ https://www.ncbi.nlm.nih.gov/pubmed/36471534 http://dx.doi.org/10.1016/j.ijcard.2022.11.051

Ejemplares similares

ECG characteristics associated with adverse outcomes in COVID-19, a tertiary centre experience
por: Bistrovic, P, et al.
Publicado: (2023)

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis
por: Bistrovic, Petra, et al.
Publicado: (2022)

Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a tertiary center registry
por: Jurin, Ivana, et al.
Publicado: (2022)

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events
por: Lucijanic, Marko, et al.
Publicado: (2023)

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS
por: Lucijanic, Marko, et al.
Publicado: (2023)

Clinical and prognostic significance of C-reactive protein to albumin ratio in hospitalized coronavirus disease 2019 (COVID-19) patients: Data on 2309 patients from a tertiary center and validation in an independent cohort
por: Lucijanić, Marko, et al.
Publicado: (2022)

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Relative tachycardia at admission as a predictor of mortality in severe and critical COVID-19, a tertiary centre study
por: Bistrovic, P, et al.
Publicado: (2023)

Survival analysis, more than meets the eye
por: Lucijanic, Marko, et al.
Publicado: (2017)

Predictors of prolonged hospitalization of COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2023)

PB2194: HIGHER JAK2 ALLELE BURDEN IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS IS ASSOCIATED WITH HIGHER PREVALENCE OF CHRONIC KIDNEY DISEASE AND UNFAVORABLE DYNAMICS OF KIDNEY FUNCTION OVER TIME
por: Lucijanic, Marko, et al.
Publicado: (2023)

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
por: Lucijanic, Marko, et al.
Publicado: (2021)

Persistent Left Superior Vena Cava in Patients Undergoing Cardiac Device Implantation: Clinical and Long-Term Data
por: Petrac, Dubravko, et al.
Publicado: (2013)

The association of ventricular tachycardia and endothelial dysfunction in the setting of acute myocardial infarction with ST elevation
por: Škerk, Vedrana, et al.
Publicado: (2013)

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS
por: Lucijanic, M., et al.
Publicado: (2022)

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry
por: Lucijanić, Marko, et al.
Publicado: (2022)

Incidence and predictors of asymptomatic atrial fibrillation in patients older than 70 years with complete atrioventricular block and dual chamber pacemaker implantation
por: Radeljić, Vjekoslav, et al.
Publicado: (2011)

ROUTINELY AVAILABLE BIOMARKERS AS LONG-TERM PREDICTORS OF DEVELOPING SYSTOLIC DYSFUNCTION IN COMPLETELY REVASCULARIZED PATIENTS WITH ACUTE ST ELEVATION MYOCARDIAL INFARCTION
por: Zeljković, Ivan, et al.
Publicado: (2019)

LEFT VENTRICULAR LEAD PLACEMENT FOR PACING AND SENSING IN A PATIENT WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY UNDERGOING ICD IMPLANTATION
por: Taleski, Jane, et al.
Publicado: (2019)

Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis
por: Lucijanic, Marko, et al.
Publicado: (2023)

PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED
por: Lucijanic, Marko, et al.
Publicado: (2023)

Noninvasive Recanalization of a Coronary Chronic Total Occlusion
por: Kos, Nikola, et al.
Publicado: (2019)

Survival analysis in clinical practice: analyze your own data using an Excel workbook
por: Lucijanić, Marko
Publicado: (2016)

An update to the custom-made MS Excel workbook performing the log-rank test with extended functionality and a new original COVID-19 training data set
por: Lucijanić, Marko
Publicado: (2021)

PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
por: Sabljic, A., et al.
Publicado: (2022)

Vaccine uptake in caregivers family members and patients with dementia and relationship with severity of dementia and caregiver burden: a cross-sectional study
por: Lucijanic, Jelena, et al.
Publicado: (2023)

P1051: CLINICAL CHARACTERISTICS OF PULMONARY EMBOLISM IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
por: Krecak, Ivan, et al.
Publicado: (2023)

Analysis of censored data
por: Lucijanic, Marko, et al.
Publicado: (2012)

Ruxolitinib withdrawal due to the COVID-19
por: Lucijanic, Marko, et al.
Publicado: (2021)

Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia
por: Krecak, Ivan, et al.
Publicado: (2023)

A validation of the Croatian version of Zarit Burden Interview and clinical predictors of caregiver burden in informal caregivers of patients with dementia: a cross-sectional study
por: Lucijanić, Jelena, et al.
Publicado: (2020)

Elastic Modulus and Elasticity Ratio of Malignant Breast Lesions with Shear Wave Ultrasound Elastography: Variations with Different Region of Interest and Lesion Size
por: Bulum, Antonio, et al.
Publicado: (2021)

Case Report for Two Siblings Carrying Neurofibromatosis Type 1 with a Rare NF1: c.5392C>T Mutation
por: Sayın Kocakap, DB, et al.
Publicado: (2022)

Patterns of anticoagulation therapy in atrial fibrillation: results from a large real-life single-center registry
por: Jurin, Ivana, et al.
Publicado: (2020)

Relationship of Anxiety, Depression, Stress, and Post-Traumatic Stress Disorder Symptoms with Disease Severity in Acutely Ill Hospitalized COVID-19 Patients
por: Lucijanic, Dijana, et al.
Publicado: (2023)

Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients
por: Pejša, Vlatko, et al.
Publicado: (2017)

High prevalence of hyperlipidaemia in patients with AV re-entry tachycardia and AV nodal re-entry tachycardia
por: Zeljković, Ivan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hpppi38p1bgn1kjcs09eqqc4oh